DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Ottoboni T, Lauw M, Keller MR. et al.
HTX-019 via 2-min injection or 30-min infusion in healthy subjects.
Future Oncol 2019;
15 (08) 865-874
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.